Compare REVG & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REVG | XENE |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.2B |
| IPO Year | 2017 | 2014 |
| Metric | REVG | XENE |
|---|---|---|
| Price | $63.90 | $41.38 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | $48.00 | ★ $54.09 |
| AVG Volume (30 Days) | 577.8K | ★ 916.9K |
| Earning Date | 03-04-2026 | 02-26-2026 |
| Dividend Yield | ★ 0.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $2,463,500,000.00 | $7,500,000.00 |
| Revenue This Year | $9.52 | N/A |
| Revenue Next Year | $7.89 | N/A |
| P/E Ratio | $33.81 | ★ N/A |
| Revenue Growth | ★ 3.50 | N/A |
| 52 Week Low | $26.51 | $26.74 |
| 52 Week High | $69.92 | $46.60 |
| Indicator | REVG | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 47.76 |
| Support Level | $66.14 | $40.30 |
| Resistance Level | $68.50 | $43.70 |
| Average True Range (ATR) | 1.81 | 1.53 |
| MACD | -0.65 | -0.01 |
| Stochastic Oscillator | 21.47 | 47.85 |
REV Group Inc is a U.S.-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services, operating through two segments: Specialty Vehicles and Recreational Vehicles. The Specialty Vehicles segment includes fire apparatus, ambulances, terminal trucks, and sweepers sold under brands such as E-One, Ferrara, KME, Spartan ER, AEV, Horton, Leader, Road Rescue, Wheeled Coach, Capacity, and LayMor. The Recreational Vehicles segment includes American Coach, Fleetwood RV, Holiday Rambler, Renegade RV, and Midwest Automotive Designs, offering Class A, B, C, and Super C motorized RVs and products from Goldshield Fiberglass. The majority of revenue is generated from the Specialty Vehicles segment.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.